Newsroom

Sorted by: Latest

-

Xtremis Awarded U.S. Army AUGUR SHIELD Contract to Advance Next-Generation Counter-UAS Capabilities

WASHINGTON--(BUSINESS WIRE)--Xtremis today announced it has been awarded a contract supporting the U.S. Army Combat Capabilities Development Command Army Research Laboratory (DEVCOM ARL) under the AUGUR SHIELD initiative, a multi-year effort to develop advanced electromagnetic spectrum capabilities that improve the detection and mitigation of increasingly sophisticated unmanned aerial system (UAS) threats. The AUGUR SHIELD program addresses the Department of War’s need to detect and counter rap...
-

Upland RightAnswers Gains AI-Powered Knowledge on Amazon Bedrock

AUSTIN, Texas--(BUSINESS WIRE)--Upland Software, Inc. (Nasdaq: UPLD), a provider of enterprise intelligence that turns knowledge, content, and data into actionable AI-powered outcomes, today announced the modernizing of Upland RightAnswers on Amazon Bedrock, expanding its KCS v6–verified knowledge management platform so that the same trusted content now powers both people and AI.This investment further cements RightAnswers as the AI Knowledge Intelligence Layer for the enterprise. Enterprise AI...
-

Deutsche Bank AG UK Regulatory Announcement: Value per Security

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 16 November 2026 COMPANY ANNOUNCEMENT Immediate Release 16 November 2026 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 13 November 2026 Series ISIN Currency Value per Secur...
-

Acadia Pharmaceuticals Enters Exclusive Distribution Agreement with KYORIN Pharmaceutical for DAYBUE® STIX (trofinetide) in Japan

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD), today announced that it has entered into an exclusive distribution agreement with KYORIN Pharmaceutical Co., Ltd. (TSE: 4569), for the commercialization of DAYBUE® STIX (trofinetide) powder for oral solution in Japan for the treatment of Rett syndrome. Under the terms of the agreement, KYORIN will be responsible for leading the commercialization of DAYBUE STIX in Japan and the related regulatory activities on behalf of Acad...
-

Instem Unveils Unified, AI-Enabled Platform to Transform Preclinical R&D

BOSTON--(BUSINESS WIRE)--Instem will launch its unified, AI-enabled Provantis platform in mid-2027, connecting preclinical study execution, analysis and SEND submission....
-

Hargrove Launches Ultra-High-Net-Worth Estate Planning Practice, Taps Former Stinson Partner Stephen Higgins to Lead Expansion

LOUISVILLE, Ky.--(BUSINESS WIRE)--Hargrove launches ultra-high-net-worth estate planning practice, appointing former Stinson partner Stephen Higgins to lead the expansion....
-

Blackstone Life Sciences Announces $750 Million R&D Funding Agreement

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blackstone announced today that funds managed by Blackstone Life Sciences (“Blackstone”) will provide $750 million in development funding to Johnson & Johnson to support the Phase 3 clinical development of OLN324, an investigational therapy for serious retinal vascular diseases. Specifically, Blackstone will finance the Phase 3 clinical program of OLN324, including wet age-related macular degeneration and diabetic macular edema, following the expected clos...
-

DataSwitch Introduces Mathi to Turn Enterprise Expertise into AI-Ready Data Pipelines

LEWES, Delaware & CHENNAI, India--(BUSINESS WIRE)--DataSwitch Introduces Mathi to Turn Enterprise Expertise into AI-Ready Data Pipelines...
-

Securities Fraud Class Action Lawsuit Pending Against Lennar Corporation: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline

BENSALEM, Pa.--(BUSINESS WIRE)--Lennar Corporation ("Lennar" or the "Company") (NYSE: LEN) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 7, 2025 through October 2, 2026, inclusive. The Law Offices of Howard G. Smith today reported the lawsuit, Triggs v. Lennar Corporation et al., which was filed on November 11, 2026 in the U.S. District Court Florida Southern District Court (Case N...
-

Air Industries Group Reminds Investors of November 18 Special Meeting for Proposed Tenax Merger

BAY SHORE, N.Y.--(BUSINESS WIRE)--Air Industries Group (NYSE American: AIRI) (“AIR” or the “Company”) today announced a reminder that it will hold a special meeting of stockholders (the “Special Meeting”) on November 18, 2026, at 10:00 A.M., Eastern Time, at 1460 Fifth Avenue, Bay Shore, New York 11706, to vote on proposals related to the merger with Tenax Aerospace Acquisition, LLC (“Tenax”). Stockholders of record as of the close of business on October 13, 2026 (the “Record Date”) are entitle...